Skip to main content
. Author manuscript; available in PMC: 2020 May 12.
Published in final edited form as: Curr Eye Res. 2018 Oct 19;44(3):264–274. doi: 10.1080/02713683.2018.1533983

Figure 1.

Figure 1.

In vitro release of aflibercept from degradable microsphere-hydrogel DDS with varied PEG-PLLA-DA concentrations and different microsphere load amount. (a) Cumulative release (μg) of aflibercept from 2 mM PEG-PLLA-DA concentration DDS with 10 and 20 mg/ml microsphere load amount. (b) Cumulative release (μg) of aflibercept from 3 mM PEG-PLLA-DA concentration DDS with 10 mg/ml and 20 mg/ml microsphere load amount. Error bars represent standard error (n = 3). Equations were obtained by applying linear regression analysis to release profiles after 7 days.